Access lists of investors who have invested $24B in biopharma startups since 2018
With $17B invested in biopharma startups in 2018, biotech is the second largest sector of venture capital after software. But there is virtually no overlap between the top biotech VCs and the top tech VCs: traditional tech VCs led less than 10% of Series A investments in biopharma startups in 2018.
Our investor lists include hundreds of biotech investors that have invested over $24B in biotech startups since January 2018. Many have recently raised large new funds.
We also include details on the startups these investors funded, including therapeutic area and development stage.
Our lists are specific to biopharma and our coverage is comparable to that of enterprise-grade solutions.
Over $23B has been invested in biopharma startups worldwide from 2018 through June 2019. But a fragmented, quickly changing investor landscape makes it difficult to target the right investors.
Only 7 investors have led more than 5 Series A rounds since 6/30/2018. The funding landscape is evolving quickly, with Chinese investors retreating, US biotech VCs increasing their activity, and generalist tech VCs playing a larger role.
Our comprehensive, manually vetted lists of investors in biopharma startups help you stay on top of these changes and find the right investors for your company.
Bay Bridge Bio supports the next generation of biotech entrepreneurs.
We organize free events and educational programs that connect PhD students and postdocs with leading biotech venture funds and experienced entrepreneurs to build relationships, find jobs, and start companies.
We created this database as part of our educational content for grad students and postdocs. We made this data available for purchase based on requests from companies interested in this data.
Our coverage of biopharma venture funding is comparable to that of enterprise-grade databases. All of our data is reviewed manually before being pushed to the database.
A photo from a VC panel we organized at UC Berkeley
Series A lead investors in US companies (167 rows, 96 unique investors)
Series A and B lead investors in US companies (264 rows, 145 unique investors)
All investors in global companies (2,098 rows, 739 unique investors)
If you are not satisfied with your purchase, let us know how we can improve and we will give you a full refund.